Two putative protein kinase CK2 phosphorylation sites are important for Myf-5 activity

Biological Chemistry

Volumn 378, Issue 12, 1997, Pages 1445-1456

  Winter, Barbara ^a   Kautzner, Iris ^a   Issinger, Olaf Georg ^b   Arnold, Hans Henning ^a  

^a TECHNICAL UNIVERSITY OF BRAUNSCHWEIG   (Germany)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Casein kinase 2; Myf 5; Myogenesis; Transcription factor

Indexed keywords

CASEIN KINASE II; GLUTAMIC ACID; MYOGENIC FACTOR 5; SERINE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DIMERIZATION; DNA BINDING; ENZYME SUBSTRATE; MUSCLE CELL; MUSCLE DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; REPORTER GENE; REPRESSOR GENE;

ANIMALIA;

EID: 0031453976     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/bchm.1997.378.12.1445     Document Type: Article

References (69)

1. Allende, J.E., and Allende, C.C. (1995). Protein kinase CK2: An enzyme with multiple substrates and a puzzling regulation. FASEB Journal 9, 313-323.
2. Arnold, H.H., and Braun, T. (1993). The developmental control genes in myogenesis of vertebrates. Adv. Dev. Biochem. 2, 111-158.
3. Arnold, H.H., and Braun, T. (1996). Targeted inactivation of myogenic factor genes reveals their role during mouse myogenesis: A review. Inter. J. Dev. Biol. 40, 345-353.
4. Bader, D., Masaki, T., and Fischman, D.A. (1982). Immunochemical analysis of myosin heavy chain during avian myogenesis in vivo and in vitro. J. Cell Biol. 95, 763-770.
5. Benezra, R., Davis, R.L., Lockshon, D., Turner, D.L., and Weintraub, H. (1990). The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell 61, 49-59.
6. Bengal, E., Ransone, L., Scharfmann, R., Dwarki, V.J., Tapscott, S.J., Weintraub, H., and Verma, I.M. (1992). Functional antagonism between c-Jun and MyoD proteins: a direct physical association. Cell 68, 507-519.
7. Berberich, S.J., and Cole, M.D. (1992). Casein kinase II inhibits the DNA-binding activity of Max homodimers but not Myc/Max heterodimers. Genes Dev. 6, 166-176.
8. Bousset, K., Oelgeschlager, M.H., Henriksson, M., Schreek, S., Burkhardt, H., Litchfield, D.W., Luscher-Firzlaff, J.M., and Luscher, B. (1994). Regulation of transcription factors c-Myc, Max, and c-Myb by casein kinase II. Cell Mol. Biol. Res. 40, 501-511.
9. Boyle, W.J., van der Geer, P., and Hunter, T. (1991). Phosphopeptide mapping and phosphoamino acid analysis by two dimensional separation on thin-layer cellulose plates. Methods Enzymol. 201, 110-149.
10. Braun, T., and Arnold, H.H. (1991). The four human muscle regulatory helix-loop-helix proteins Myf3-Myf6 exhibit similar hetero-dimerization and DNA binding properties. Nucleic Acids Res. 19, 5645-5651.
11. Braun, T., Buschhausen-Denker, G., Bober, E., Tannich, E., and Arnold, H.H. (1989). A novel human muscle factor related to but distinct from MyoD1 induces myogenic conversion in 10T1/2 fibroblasts. Embo J. 8, 701-709.
12. Braun, T., Bober, E., Buschhausen-Denker, G., Kohtz, S., Grzeschik, K.H., Kotz, S., and Arnold, H.H. (1989b). Differential expression of myogenic determination genes in muscle cells: possible autoactivation by the Myf gene products Embo J. 8, 3617-3625.
13. Braun, T., Winter, B., Bober, E., and Arnold, H.H. (1990). Transcriptional activation domain of the muscle-specific gene-regulatory protein myf-5. Nature 346, 663-665.
14. Brennan, T.J., and Olson, E.N. (1990). Myogenin resides in the nucleus and acquires high affinity for a conserved enhancer element on heterodimerization. Genes Dev. 4, 582-595.
15. Carroll, D., and Marshak, D.R. (1989). Serum-stimulated cell growth causes oscillations in casein kinase II activity. J. Biol. Chem. 264, 7345-7348.
16. Chakraborty, T., Brennan, T., and Olson, E.N. (1991). Differential trans-activation of a muscle-specific enhancer by myogenic helix-loop-helix proteins is separable from DNA binding. J. Biol. Chem. 266, 2878-2882.
17. Davis, R.L., Weintraub, H., and Lassar, A.B. (1987). Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 51, 987-1000.
18. Edmondson, D.G., and Olson, E.N. (1989). A gene with homology to the myc similarity region of MyoD1 is expressed during myogenesis and is sufficient to activate the muscle differentiation program. Genes Dev. 3, 628-640.
19. Edmondson, D.G., Brennan, T.J., and Olson, E.N. (1991). Mitogenic repression of myogenin autoregulation. J. Biol. Chem. 266, 21343-21346.
20. Falcone, G., Gauzzi, M.C., Tato, F., and Alema, S. (1990). Differential control of muscle-specific gene expression specified by src and myc oncogenes in myogenic cells. Ciba Found. Symp. 150, 250-258; discussion 258-261.
21. Glineur, C., Bailly, M., and Ghysdael, J. (1989). The c-erbA alpha-encoded thyroid hormone receptor is phosphorylated in its amino terminal domain by casein kinase 11. Oncogene 4, 1247-1254.
22. Gorman, C. (1985). High efficiency gene transfer into mammalian cells. In: DNA Cloning, Volume II, D.M. Glover, eds. (Oxford: IRL Press), pp. 143-190.
23. Henthorn, P., Kiledjian, M., and Kadesch, T. (1990). Two distinct transcription factors that bind the immunoglobulin enhancer microE5/kappa2 motif. Science 247, 467-470.
24. Heriche, J.K., Lebrin, F., Rabilloud, T., Leroy, D., Chambaz, E.M., and Goldberg, Y. (1997). Regulation of protein phosphatase 2A by direct interaction with casein kinase 2 a. Science, 276, 952-955.
25. Issinger, O.G. (1993). Casein kinases: pleiotropic mediators of cellular regulation. Pharmacol Ther. 59, 1-30.
26. Johnson, S.E., Wang, X., Hardy, S., Taparowsky, E.J., and Konleczny, S.F. (1996). Casein kinase II increases the transcriptional activities of MRF4 and MyoD independently of their direct phosphorylation. Mol. Cell Biol. 16, 1604-1613.
27. Kong, Y., Johnson, S.E., Taparowsky, E.J., and Konieczny, S.F. (1995). Ras p21-Val inhibits myogenesis without altering the DNA binding or transcriptional activities of the myogenic basic helix-loop-helix factors. Mol. Cell Biol. 15, 5205-5213.
28. Konieczny, S.F., Drobes, B.L., Menke, S.L., and Taparowsky, E.J. (1989). Inhibition of myogenic differentiation by the H-ras oncogene is associated with the down regulation of the MyoD1 gene. Oncogene, 4, 473-481.
29. Krek, W., Maridor, G., and Nigg, E.A. (1992). Casein kinase II is a predominantly nuclear enzyme. J. Cell Biol. 116, 43-55.
30. Lassar, A.B., Buskin, J.N., Lockshon, D., Davis, R.L., Apone, S., Hauschka, S.D., and Weintraub, H. (1989). MyoD is a sequence-specific DNA binding protein requiring a region of myc homology to bind to the muscle creatine kinase enhancer. Cell 58, 823-831.
31. Lassar, A.B., Davis, R.L., Wright, W.E., Kedesch, T., Murre, C., Voronova, A., Baltimore, D., and Weintraub, H. (1991). Functional activity of myogenic HLH proteins requires heterooligomerization with E12/E47-like proteins in vivo. Cell 66, 305-315.
32. Li, L., Chambard, J.C., Karin, M., and Olson, E.N. (1992). Fos and Jun repress transcriptional activation by myogenin and MyoD: the amino terminus of Jun can mediate repression. Genes Dev. 6, 676-689.
33. Lin, A., Frost, J., Deng, T., Smeal, T., al Alawi, N., Kikkawa, U., Hunter, T., Brenner, D., and Karin, M. (1992). Casein kinase II is a negative regulator of c-Jun DNA binding and AP-1 activity. Cell 70, 777-789.
34. Litchfield, D.W., and Luscher, B. (1993). Casein kinase II in signal transduction and cell cycle regulation. Mol. Cell Biochem. 128, 187-199.
35. Lorenz, P., Pepperkok, R., Ansorge, W., and Pyerin, W. (1993). Cell biological studies with monoclonal and polyclonal antibodies against human casein kinase II subunit beta demonstrate participation of the kinase in mitogenic signaling. J. Biol. Chem. 268, 2733-2739.
36. Mak, K.L., To, R.Q., Kong, Y., and Konieczny, S.F. (1992). The MRF4 activation domain is required to induce muscle-specific gene expression. Mol. Cell Biol. 12, 4334-4346.
37. Manak, J.R., de Bisshop, N., Kris, R.M. and Prywes, R. (1990). Casein kinase II enhances the DNA binding activity of serum response factor. Genes Dev. 4, 955-967.
38. Martin, J.F., Li, L., and Olson, E.N. (1992). Repression of myogenin function by TGF-beta 1 is targeted at the basic helix-loop-helix motif and is independent of E2A products. J. Biol. Chem. 267, 10956-10960.
39. Meggio, F., Perich, J.W., Reynolds, E.C., and Pinna, L.A. (1991). A synthetic beta-casein phosphopeptide and analogues as model substrates for casein kinase-1, a ubiquitous, phosphate directed protein kinase. Febs Lett. 283, 303-306.
40. Miner, J.H., and Wold, B.J., (1990). Herculin, a fourth member of the MyoD family of myogenic regulatory genes. Proc. Natl. Acad. Sci. USA 87, 1089-1093.
41. Miner, J.H., and Wold, B.J. (1991). c-myc inhibition of MyoD and myogenin-initiated myogenic differentiation. Mol. Cell Biol. 11, 2842-2851.
42. Molkentin, J.D., Li, L., and Olson, E.N. (1996). Phosphorylation of the MADS-box transcription factor MEF2C enhances its DNA binding activity. J. Biol. Chem. 271, 17199-17204.
43. Murre, C., McCraw, P.S., and Baltimore, D. (1989). A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins. Cell 56, 777-783.
44. Norman, C., and Treisman, R. (1988). Analysis of serum response element function in vitro. Cold Spring Harb. Symp. Quant. Biol. 53, 719-726.
45. Olson, E.N. (1992). Interplay between proliferation and differentiation within the myogenic lineage. Dev. Biol. 154, 261-272.
46. Pepperkok, R., Lorenz, P., Ansorge, W., and Pyerin, W. (1994). Casein kinase II is required for transition of GO/G1, early G1, and G1/S phases of the cell cycle. J. Biol. Chem. 269, 6986-6991.
47. Rhodes, S.J., and Konieczny, S.F. (1989). Identification of MRF4: a new member of the muscle regulatory factor gene family. Genes Dev. 3, 2050-2061.
48. Rosenthal, N., Berglund, E.B., Wentworth, B.M., Donoghue, M., Winter, B., Bober, E., Braun, T., and Arnold, H.H. (1990). A highly conserved enhancer downstream of the human MLC1/3 locus is a target for multiple myogenic determination factors. Nucleic Acids Res. 18, 6239-6246.
49. Rudnicki, M.A., Schnegelsberg, P.N., Stead, R.H., Braun, T., Arnold, H.H., and Jaenisch, R. (1993). MyoD or Myf-5 is required for the formation of skeletal muscle. Cell 75, 1351-1359.
50. Salminen, A., Braun, T., Buchberger, A., Jurs, S., Winter, B., and Arnold, H.H. (1991). Transcription of the muscle regulatory gene Myf4 is regulated by serum components, peptide growth factors and signaling pathways involving G proteins. J. Cell Biol. 115, 905-917.
51. Schwartz, E.D., van Antwerp, D., and Verma, I.M. (1996). Constitutive phosphorylation of IKBα by casein kinase II occurs preferentially at serine 293: Requirement for degradation of free IKBα. Mol. Cell Biol. 16, 3554-3559.
52. Schwarz, J.J., Chakraborty, T., Martin, J., Zhou, J.M., and Olson, E.N. (1992). The basic region of myogenin cooperates with two transcription activation domains to induce muscle-specific transcription. Mol. Cell Biol. 12, 266-275.
53. Sefton, B.M., Hunter, T., and Beemon, K. (1980). Temperature-sensitive transformation by Rous sarcoma virus and temperature-sensitive protein kinase activity. J. Virol. 33, 220-229.
54. Seldin, D.C., and Leder, P. (1995). Casein kinase II-alpha trans-gene-induced murine lymphoma: Relation to Theileriosis in cattle. Science 267, 894-897.
55. Shirakata, M., Friedman, F.K., Wei, Q., and Paterson, B.M. (1993). Dimerization specificity of myogenic helix-loop-helix DNA-binding factors directed by nonconserved hydrophilic residues. Genes Dev. 7, 2456-2470.
56. Shirakata, M., and Paterson, B.M. (1995). The E12 inhibitory domain prevents homodimer formation and facilitates selective heterodimerization with the MyoD family of gene regulatory factors. Embo J. 14, 1766-1772.
57. Sloan, S.R., Shen, C.P., McCarrick-Walmsley, R., and Kadesch, T. (1996). Phosphorylation of E47 as a potential determinant of B-cell specific activity. Mol. Cell Biol. 16, 6900-6908.
58. Stigare, J.B., N., Pigon, A., and Egyhazi, E. (1994). Analysis of a novel DNA-binding protein kinase CKII-like enzyme of Chironomus cells. Cell Mol. Biol Res. 40, 463-472.
59. Tapscott, S.J., Davis, R.L., Thayer, M.J., Cheng, P.F., Weintraub, H., and Lassar, A.B. (1988). MyoD1: a nuclear phosphoprotein requiring a Myc homology region to convert fibroblasts to myoblasts. Science 242, 405-411.
60. Thayer, M.J., Tapscott, S.J., Davis, R.L., Wright, W.E., Lassar, A.B., and Weintraub, H. (1989). Positive autoregulation of the myogenic determination gene MyoD1. Cell 58, 241-248.
61. Tsurumi, C., Ishida, N., Tamura, T., Kakizuka, A., Nishida, E., Okumura, E., Kishimoto, T., Inagaki, M., Okazaki, K., Sagata, N., Ichihara, A., and Tanaka, K. (1995). Degradation of c-Fos by the 26S proteasome is accelerated by c-Jun and multiple protein kinases. Mol. Cell Biol. 15, 5682-5687.
62. Vaidya, T.B., Rhodes, S J., Taparowsky, E.J., and Konieczny, S.F. (1989). Fibroblast growth factor and transforming growth factor beta repress transcription of the myogenic regulatory gene MyoD1. Mol. Cell Biol. 9, 3576-3579.
63. Wada, T., Takagi, T. Yamaguchi, Y., Kawase, H., Hiramoto, M., Ferdous, A., Takayamy, M., Lee, K.A.W., Hurst, H.C., and Handa, H. (1996). Copurification of casein kinase II with transcription factor ATF/E4TF3. Nucleic Acids Research 24, 876-884.
64. Weintraub, H. (1993). The MyoD family and myogenesis: redundancy, networks, and thresholds. Cell 75, 1241-1244.
65. Weintraub, H., Davis, R., Tapscott, S., Thayer, M., Krause, M., Benezra, R., Blackwell, T.K., Turner, D., Rupp, R., and Hollenberg, S. (1991a). The myoD gene family: nodal point during specification of the muscle cell lineage. Science 251, 761-766.
66. Weintraub, H., Dwarki, V.J., Verma, I., Davis, R., Hollenberg, S., Snider, L., Lassar, A., and Tapscott, S.J. (1991b). Muscle-specific transcriptional activation by MyoD. Genes Dev. 5, 1377-1386.
67. Winter, B., Braun, T., and Arnold, H.H. (1992). Co-operativity of functional domains in the muscle-specific transcription factor Myf-5. EmboJ. 11, 1843-1855.
68. Winter, B., Braun, T., and Arnold, H.H. (1993). cAMP-dependent protein kinase represses myogenic differentiation and the activity of the muscle-specific helix-loop-helix transcription factors Myf-5 and MyoD. J. Biol. Chem. 268, 9869-9878.
69. Wright, W.E., Sassoon, D.A., and Lin, V.K. (1989). Myogenin, a factor regulating myogenesis, has a domain homologous to MyoD. Cell 56, 607-617.